Real-world efficacy of nivolumab plus cabozantinib in metastatic renal cell carcinoma (mRCC) using the IMDC.Martín Zarbá, Daniel Yick Chin Heng, David Maj et al.|Journal of Clinical Oncology|2026Cited by 0
Efficacy and safety of belzutifan in patients with metastatic clear cell renal cell carcinoma (mccRCC): Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).Chris Labaki, Rana R. McKay, Razane El Hajj Chehade et al.|Journal of Clinical Oncology|2026Cited by 0